The significance of the hemochromatosis genetic variants in multiple myeloma in comparison to that of myelodysplastic syndrome

[1]  P. Brissot.  The discovery of the new haemochromatosis gene , 2003 .

[2]  A. Tordai,et al.  High Incidence of Hemochromatosis Gene Mutations in the Myelodysplastic Syndrome: The Budapest Study on 50 Patients , 2003, Acta Haematologica.

[3]  G. Hallmans,et al.  Interaction between haemochromatosis and transferrin receptor genes in different neoplastic disorders. , 1999, Carcinogenesis.

[4]  B. Grosbois,et al.  Haemochromatosis Cys282Tyr mutation in pyridoxine-responsive sideroblastic anaemia , 1997, The Lancet.

[5]  M. C. Ellis,et al.  A novel MHC class I–like gene is mutated in patients with hereditary haemochromatosis , 1996, Nature Genetics.

[6]  D. Hossfeld,et al.  Trisomy 8 preceding diagnosis of acute nonlymphocytic leukemia by 2 years in a patient with multiple myeloma without cytological evidence of myelodysplasia , 1996, Annals of Hematology.

[7]  F. Davis,et al.  Risk of neoplastic and other diseases among people with heterozygosity for hereditary hemochromatosis , 1995, Cancer.

[8]  Teiji Takei,et al.  [The significance of myelodysplasia in untreated patients with multiple myeloma]. , 1992, [Rinsho ketsueki] The Japanese journal of clinical hematology.

[9]  M. Franchini,et al.  Iron overload and hematologic malignancies. , 2004, The hematology journal : the official journal of the European Haematology Association.

[10]  A. Cao,et al.  H63D mutation in the HFE gene increases iron overload in beta-thalassemia carriers. , 2002, Haematologica.